BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta

Phase 1

Completed

Conditions: Osteogenesis Imperfecta

Interventions: Drug: Fresolimumab

First Posted Date: 2017-02-24

Last Posted Date: 2024-12-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 11

Registration Number: NCT03064074

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Oregon Health Science University, Portland, Oregon, United States

Open Myelomeningocele Repair With High Maternal BMI

Not Applicable

Terminated

Conditions: Neural Tube Defect

Interventions: Procedure: Open-Uterus Fetal Repair

First Posted Date: 2017-02-07

Last Posted Date: 2019-08-01

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 1

Registration Number: NCT03044821

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume

Completed

Conditions: Birth Weight
Fetal Growth Retardation
Fetal Weight
Fetal Macrosomia

Interventions: Other: Ultrasound Examination

First Posted Date: 2016-12-23

Last Posted Date: 2019-07-23

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 330

Registration Number: NCT03002246

Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade

Not Applicable

Conditions: Bladder Cancer

Interventions: Procedure: Bladder tumor biopsy

First Posted Date: 2016-12-14

Last Posted Date: 2022-01-19

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 30

Registration Number: NCT02992990

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Fetal Hemoglobin Induction Treatment Metformin

Early Phase 1

Completed

Conditions: Hemoglobin Disorder
Sickle Cell Anemia
Sickle Cell Disease

Interventions: Drug: Metformin
Behavioral: Questionnaires

First Posted Date: 2016-12-05

Last Posted Date: 2023-10-12

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 37

Registration Number: NCT02981329

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Psychosis

Interventions: Device: transcranial direct current stimulation

First Posted Date: 2016-11-29

Last Posted Date: 2020-11-25

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 15

Registration Number: NCT02975973

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)

Phase 1

Completed

Conditions: EBV Related Non-Hodgkin's Lymphoma
EBV-Related PTLD
EBV Related Lymphoma
Hodgkin Lymphoma
NonHodgkin Lymphoma
Lymphoproliferative Disorders
EBV Related Hodgkin's Lymphoma

Interventions: Biological: EBVST Cells
Biological: Nivolumab

First Posted Date: 2016-11-25

Last Posted Date: 2021-07-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 8

Registration Number: NCT02973113

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)

Phase 4

Completed

Conditions: Severe Obesity
Hypogonadism

Interventions: Drug: Anastrazole
Behavioral: weight loss

First Posted Date: 2016-11-09

Last Posted Date: 2020-01-30

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 23

Registration Number: NCT02959853

Locations: 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States

Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma

Phase 1

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Metformin

First Posted Date: 2016-10-31

Last Posted Date: 2023-06-29

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 26

Registration Number: NCT02949700

Locations: 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
🇺🇸
Harris Health System - Smith Clinic, Houston, Texas, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants

Not Applicable

Active, not recruiting

Conditions: Premature Infants

Interventions: Dietary Supplement: Standard Protein Diet
Dietary Supplement: High Protein Diet

First Posted Date: 2016-10-25

Last Posted Date: 2025-02-25

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 118

Registration Number: NCT02943746

Locations: 🇺🇸
Baylor College of Medicine / Texas Children's Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy